Call 800 665 0411 to learn about our services for your stock

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

AID:Tech partners with PharmAccess to Transform Antenatal Care in #Tanzania Through #Blockchain Technology

Announcement comes as the initiative sees Africa's first baby born on the blockchain


Dublin, Ireland - June 1, 2018 ( Newswire) AID:Tech, the company that uses Digital Identity and Blockchain technology to revolutionize how governments, enterprises and NGOs deliver digital entitlements, today announced an ongoing partnership with PharmAccess Foundation, the group dedicated to improving access to healthcare throughout Africa. The partnership has been running an initiative called Chain of Trust (CoT) which has been monitoring digitally guided pregnancies through blockchain technology. The first baby from the initiative is due to be delivered today, June 1, 2018, marking a significant milestone for both companies involved, and the Tanzanian healthcare system as a whole.

Commenting on the announcement, Niall Dennehy, COO of AID:Tech said: "From a lack of healthcare funding to high child and maternal mortality rates, there are a number of challenges present within the healthcare system in Tanzania, all of which can and will be combated. By utilizing AID:Tech's Blockchain platform we are facilitating the collection, identification, and verification of digital health data to make women's antenatal care a far safer and effective process. All the time protecting the women's data and allowing them to have full control of their health records."

Monique Dolfing, CEO of PharmAccess said, "As an organization we are dedicated to using technological innovation to provide access to better healthcare for as many people in Africa as possible. Our partnership with AID:Tech allows us to address the challenges associated with current practices while improving the lives of the patients. This project demonstrates a transparent, innovative, performance-based financing model for healthcare."

Launched on April 25th, the CoT project is already providing evidence leading to informed decision making. It tracks the journey of pregnant women from their first hospital visit at 16 weeks, monitors their antenatal care throughout, the delivery, and subsequent postnatal care at the trial clinic. In addition, AID:Tech and PharmAccess can ensure that patients will receive their medical entitlements in an efficient and transparent way, as well as supporting the care provider with tools to gather data quickly on the information of each patient's journey and manage appointments. Ultimately, the CoT project aims to provide a proof-of-concept for the efficacy of blockchain technology in assembling, tagging and verifying digital health data.

Founded in 2014, AID:Tech was the first company in the world to deliver international aid using blockchain technology. In a ground-breaking project in Tripoli, Northern Lebanon, the company utilized their platform to transparently deliver aid to Syrian refugees. AID:Tech's platform enables entitlements like aid, welfare, remittances, donations, and healthcare to be digitized and delivered through  blockchain technology in a completely transparent manner.

Founded in 2001, PharmAccess has initiated a digital platform that connects all parties in the healthcare industry, bringing transparency, accountability and direct access to and for end-users. Dedicated to improving access to better healthcare in Africa, PharmAccess is uniquely mobilizing both public and private resources for the benefit of both doctors and patients. PharmAccess places mobile technology at the forefront of its work across clinical standards, care quality improvements, loans for healthcare providers, health insurance, mobile health innovations, and research.

"Offering financial and medical solutions to people in need not only has the potential to transform lives but to ultimately save them. The results we expect to see will have untold impact on the lives of these individual women and their children, and we are delighted to welcome the first baby born from this program," concluded Dennehy.

For more information visit &

Niall Dennehy COO of AID:Tech and Monique Dolfing, CEO of PharmAccess are available for interview

About AID:Tech

Founded in 2014, AID:Tech was the first company in the world to deliver international aid using blockchain technology in 2015. In a ground-breaking project in Tripoli, Northern Lebanon, the company utilized their platform to transparently deliver aid to Syrian refugees. AID:Tech's platform enables entitlements like aid, welfare, remittances, donations and healthcare to be digitised and transparently delivered to end users through  blockchain technology in a completely transparent manner. In addition to winning numerous awards, AID:Tech claimed the Citi Tech4Integrity challenge award at the IMF last year and received the James Wolfensohn game changer award from managing director Madame Christine Lagarde.

Media Contact:

Alex Sheehan
Account Supervisor//Wachsman // +353 87 097 9702 features content for Bitcoin, Blockchain and Digital Currency Stocks and ICO's at, and

View our growing Bitcoin, Blockchain and Digital Currency Stocks Directory

Join our LinkedIn Group Blockchain and Digital Currency Stocks and ICO's Latest News and Commentary

Check out our crypto blog on

Recently added at

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire

Global investors must adhere to regulations of each country. Please read privacy policy:

That's all it takes to get an article published on Investor Ideas - Learn More